Belpointe Asset Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,241
| Closed | -$56.1K | – | 1148 |
|
|
2023
Q1 | $56.1K | Hold |
1,241
| – | – | ﹤0.01% | 1629 |
|
|
2022
Q4 | $50.4K | Buy |
+1,241
| New | +$50.4K | ﹤0.01% | 1607 |
|
|
2021
Q4 | – | Sell |
-1,536
| Closed | -$173K | – | 1209 |
|
|
2021
Q3 | $173K | Buy |
1,536
+536
| +54% | +$60.4K | 0.01% | 910 |
|
|
2021
Q2 | $162K | Sell |
1,000
-1,617
| -62% | -$262K | 0.01% | 918 |
|
|
2021
Q1 | $319K | Buy |
+2,617
| New | +$319K | 0.03% | 580 |
|